Pancreatic Cancer Research

ResearcherUniversity of WashingtonActive in the last 2 years

Zhibin Bai

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102593088. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. ETV1 transcriptional manipulation of KIFC1 regulates the progression of pancreatic cancer. First author DOI 10.32604/or.2025.059631↗
  2. A five-gene prognosis model based on lysine β-hydroxybutyrylation site genes to predict the survival and therapy response in pancreatic adenocarcinoma. First author DOI 10.1016/j.heliyon.2024.e34284↗
  3. The underlying molecular mechanism of intratumoral radiofrequency hyperthermia-enhanced chemotherapy of pancreatic cancer. Co-author DOI 10.1016/j.jimed.2022.02.002↗
  4. Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer. Co-author DOI 10.18632/oncotarget.12295↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fangfang Hu · 1 shared paper, 2025 · strength 0.33
  2. Jiahua Zhou · 1 shared paper, 2025 · strength 0.33
  3. Fangfang Hu · 1 shared paper, 2024 · strength 0.28
  4. Jiahua Zhou · 1 shared paper, 2024 · strength 0.28
  5. Xiaoming Yang · 2 shared papers, 2017–2022 · strength 0.28
  6. Liang-Cai Zhao · 1 shared paper, 2022 · strength 0.20
  7. Feng Zhang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.